Clinical Trial Update: Is More Than One Dose of Misoprostol Needed to Expedite Vaginal Delivery in a Patient With an Unripe Cervix? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether multiple doses of misoprostol speed vaginal delivery in women with an unripe cervix; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Induction of Labor
• Labor and Delivery Complications
• Unripe Cervix

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Labor; Forced or Induced, Affecting Fetus or Newborn | Phase 2 | Status: COMPLETED | Results posted: 2021-07-09